drugset / Trial / NCT01765114

A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes

NCT01765114 ↗

Phase 2 Terminated 8 enrolled Devirex AG
NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is therefore to investigate the efficacy of the PEG-formulation to reduce the frequency and duration of genital herpes recurrences, to assess its safety and tolerability and to investigate its effect on shedding.

Timeline

Start
2013-02
Primary completion
2014-08
Completion
2014-08

Outcome

Outcome not reported

Stopped (Enrollment): “insufficient patient recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject PEG-Formulation Unknown — —

Indications